These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
155 related articles for article (PubMed ID: 30120404)
1. In a pilot study, reduced fatty acid desaturase 1 function was associated with nonalcoholic fatty liver disease and response to treatment in children. Nobili V; Alisi A; Liu Z; Liang T; Crudele A; Raponi M; Lin J; Chalasani NP; Liu W Pediatr Res; 2018 Nov; 84(5):696-703. PubMed ID: 30120404 [TBL] [Abstract][Full Text] [Related]
2. Fatty Acid Desaturase 1 Influences Hepatic Lipid Homeostasis by Modulating the PPARα-FGF21 Axis. Athinarayanan S; Fan YY; Wang X; Callaway E; Cai D; Chalasani N; Chapkin RS; Liu W Hepatol Commun; 2021 Mar; 5(3):461-477. PubMed ID: 33681679 [TBL] [Abstract][Full Text] [Related]
3. Efficacy of docosahexaenoic acid-choline-vitamin E in paediatric NASH: a randomized controlled clinical trial. Zöhrer E; Alisi A; Jahnel J; Mosca A; Della Corte C; Crudele A; Fauler G; Nobili V Appl Physiol Nutr Metab; 2017 Sep; 42(9):948-954. PubMed ID: 28511023 [TBL] [Abstract][Full Text] [Related]
4. Fatty acid metabolism is altered in non-alcoholic steatohepatitis independent of obesity. Walle P; Takkunen M; Männistö V; Vaittinen M; Lankinen M; Kärjä V; Käkelä P; Ågren J; Tiainen M; Schwab U; Kuusisto J; Laakso M; Pihlajamäki J Metabolism; 2016 May; 65(5):655-666. PubMed ID: 27085774 [TBL] [Abstract][Full Text] [Related]
5. Targeted Knockdown of Hepatic Δ-5 Fatty Acid Desaturase FADS1 Aggravates Atherosclerosis in ApoE Liu Q; Wang P; Yang Z; Dai Y; Wang S Front Biosci (Landmark Ed); 2024 Mar; 29(4):131. PubMed ID: 38682200 [TBL] [Abstract][Full Text] [Related]
6. Carrying minor allele of FADS1 and haplotype of FADS1 and FADS2 increased the risk of metabolic syndrome and moderate but not low fat diets lowered the risk in two Korean cohorts. Park S; Kim DS; Kang S Eur J Nutr; 2019 Mar; 58(2):831-842. PubMed ID: 29779171 [TBL] [Abstract][Full Text] [Related]
7. A double-blind, placebo-controlled randomized trial to evaluate the efficacy of docosahexaenoic acid supplementation on hepatic fat and associated cardiovascular risk factors in overweight children with nonalcoholic fatty liver disease. Pacifico L; Bonci E; Di Martino M; Versacci P; Andreoli G; Silvestri LM; Chiesa C Nutr Metab Cardiovasc Dis; 2015 Aug; 25(8):734-41. PubMed ID: 26026214 [TBL] [Abstract][Full Text] [Related]
8. Alternation of plasma fatty acids composition and desaturase activities in children with liver steatosis. Hua MC; Su HM; Yao TC; Kuo ML; Lai MW; Tsai MH; Huang JL PLoS One; 2017; 12(7):e0182277. PubMed ID: 28759573 [TBL] [Abstract][Full Text] [Related]
9. Fads1 and 2 are promoted to meet instant need for long-chain polyunsaturated fatty acids in goose fatty liver. Osman RH; Liu L; Xia L; Zhao X; Wang Q; Sun X; Zhang Y; Yang B; Zheng Y; Gong D; Geng T Mol Cell Biochem; 2016 Jul; 418(1-2):103-17. PubMed ID: 27344166 [TBL] [Abstract][Full Text] [Related]
10. Liver DNA methylation of FADS2 associates with FADS2 genotype. Walle P; Männistö V; de Mello VD; Vaittinen M; Perfilyev A; Hanhineva K; Ling C; Pihlajamäki J Clin Epigenetics; 2019 Jan; 11(1):10. PubMed ID: 30654845 [TBL] [Abstract][Full Text] [Related]
11. Hydroxytyrosol prevents reduction in liver activity of Δ-5 and Δ-6 desaturases, oxidative stress, and depletion in long chain polyunsaturated fatty acid content in different tissues of high-fat diet fed mice. Valenzuela R; Echeverria F; Ortiz M; Rincón-Cervera MÁ; Espinosa A; Hernandez-Rodas MC; Illesca P; Valenzuela A; Videla LA Lipids Health Dis; 2017 Apr; 16(1):64. PubMed ID: 28395666 [TBL] [Abstract][Full Text] [Related]
13. Amelioration of non-alcoholic fatty liver disease with NPC1L1-targeted IgY or n-3 polyunsaturated fatty acids in mice. Bae JS; Park JM; Lee J; Oh BC; Jang SH; Lee YB; Han YM; Ock CY; Cha JY; Hahm KB Metabolism; 2017 Jan; 66():32-44. PubMed ID: 27923447 [TBL] [Abstract][Full Text] [Related]
14. Different Effects of Eicosapentaenoic and Docosahexaenoic Acids on Atherogenic High-Fat Diet-Induced Non-Alcoholic Fatty Liver Disease in Mice. Suzuki-Kemuriyama N; Matsuzaka T; Kuba M; Ohno H; Han SI; Takeuchi Y; Isaka M; Kobayashi K; Iwasaki H; Yatoh S; Suzuki H; Miyajima K; Nakae D; Yahagi N; Nakagawa Y; Sone H; Yamada N; Shimano H PLoS One; 2016; 11(6):e0157580. PubMed ID: 27333187 [TBL] [Abstract][Full Text] [Related]
15. MicroRNA-193a-5p Regulates the Synthesis of Polyunsaturated Fatty Acids by Targeting Fatty Acid Desaturase 1 ( Fan Y; Arbab AAI; Zhang H; Yang Y; Lu X; Han Z; Yang Z Biomolecules; 2021 Jan; 11(2):. PubMed ID: 33504005 [TBL] [Abstract][Full Text] [Related]
16. Exendin‑4, a glucagon‑like peptide‑1 receptor agonist, modulates hepatic fatty acid composition and Δ‑5‑desaturase index in a murine model of non‑alcoholic steatohepatitis. Kawaguchi T; Itou M; Taniguchi E; Sata M Int J Mol Med; 2014 Sep; 34(3):782-7. PubMed ID: 24993337 [TBL] [Abstract][Full Text] [Related]
17. Effect of FADS1 SNPs rs174546, rs174547 and rs174550 on blood fatty acid profiles and plasma free oxylipins. Rabehl M; Wei Z; Leineweber CG; Enssle J; Rothe M; Jung A; Schmöcker C; Elbelt U; Weylandt KH; Pietzner A Front Nutr; 2024; 11():1356986. PubMed ID: 39021601 [TBL] [Abstract][Full Text] [Related]
18. Genetic variants of the FADS1 FADS2 gene cluster are associated with altered (n-6) and (n-3) essential fatty acids in plasma and erythrocyte phospholipids in women during pregnancy and in breast milk during lactation. Xie L; Innis SM J Nutr; 2008 Nov; 138(11):2222-8. PubMed ID: 18936223 [TBL] [Abstract][Full Text] [Related]
19. Altered hepatic gene expression in nonalcoholic fatty liver disease is associated with lower hepatic n-3 and n-6 polyunsaturated fatty acids. Arendt BM; Comelli EM; Ma DW; Lou W; Teterina A; Kim T; Fung SK; Wong DK; McGilvray I; Fischer SE; Allard JP Hepatology; 2015 May; 61(5):1565-78. PubMed ID: 25581263 [TBL] [Abstract][Full Text] [Related]
20. Comparison of Gene Expression Patterns Between Mouse Models of Nonalcoholic Fatty Liver Disease and Liver Tissues From Patients. Teufel A; Itzel T; Erhart W; Brosch M; Wang XY; Kim YO; von Schönfels W; Herrmann A; Brückner S; Stickel F; Dufour JF; Chavakis T; Hellerbrand C; Spang R; Maass T; Becker T; Schreiber S; Schafmayer C; Schuppan D; Hampe J Gastroenterology; 2016 Sep; 151(3):513-525.e0. PubMed ID: 27318147 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]